Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ulcerative Colitis (UC)
Clinical trial register · United States · industry-sponsored

Ulcerative Colitis (UC) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9128 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 04 Nov 2026, 03:16 UTC
9128
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2189
Lead sponsors
across recruiting studies
Top states
Florida 8 California 6 Arizona 5 Illinois 5 Colorado 4
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Ulcerative Colitis (UC) trials in the USA

10 of 9128 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Vanda Pharmaceuticals
Phase 3
150
California, Tennessee
2026-09
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
Palisade Bio
Phase 2
204
Arizona, California, Connecticut, Florida, Illinois, Louisiana, Mississippi, Missouri
2026-08-28
Recruiting
Metagen Therapeutics, Inc.
Phase 1/2
54
Florida, Massachusetts, New York
2026-07-09
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana
2026-03-26
Not yet open
Rubix LS
Phase 4
150
Massachusetts
2025-07-16
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
DrugMT-201
Mirador Therapeutics, Inc.
Phase 2
140
Alabama, Arizona, Arkansas, Colorado, Florida, Georgia, Illinois, Louisiana
2025-06-26
Recruiting
Xencor, Inc.
Phase 1/2
270
Arizona, California, Florida, Kentucky, Mississippi, New York, North Carolina, Ohio
2024-10-10
Active, closed
AbbVie
Phase 3
1,242
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas
2018-08-28
Active, closed
AbbVie
Phase 3
950
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois
2017-01-31
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/ulcerative-colitis-uc

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,128 studies in total at the last sync on 04 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Ulcerative Colitis (UC).

How many Ulcerative Colitis (UC) trials are recruiting in the US?

7 of the 10 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ulcerative Colitis (UC)), 10 studies
PhaseStudiesRecruitingShare
Phase 23330%
Phase 33130%
Phase 1/22220%
Phase 11110%
Phase 41010%

Most active sponsors

Lead sponsors with the most studies (Ulcerative Colitis (UC))
Lead sponsorStudiesRecruiting
AbbVie20
Eli Lilly and Company11
Metagen Therapeutics, Inc.11
Mirador Therapeutics, Inc.11
Ono Pharmaceutical Co., Ltd.11
Palisade Bio11
Rubix LS10
Vanda Pharmaceuticals11
Xencor, Inc.11

Top states

Top states (Ulcerative Colitis (UC)), by number of studies with a site there
StateStudies
Florida8
California6
Arizona5
Illinois5
Colorado4
Connecticut4
Georgia3
Alabama2
Indiana2
Louisiana2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.